4//SEC Filing
Bratica Joseph 4
Accession 0001209191-20-045321
CIK 0000873303other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 8:00 PM ET
Size
8.9 KB
Accession
0001209191-20-045321
Insider Transaction Report
Form 4
Bratica Joseph
Principal Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2020-08-03$29.60/sh+1,125$33,300→ 8,957 total - Sale
Common Stock
2020-08-03$155.00/sh−1,125$174,375→ 7,832 total - Exercise/Conversion
Stock Option (right to buy)
2020-08-03−1,125→ 5,625 totalExercise: $29.60From: 2018-03-31Exp: 2027-03-31→ Common Stock (1,125 underlying)
Footnotes (1)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction.
Documents
Issuer
Sarepta Therapeutics, Inc.
CIK 0000873303
Entity typeother
Related Parties
1- filerCIK 0001820070
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 8:00 PM ET
- Size
- 8.9 KB